WINTAC LIMITED More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 01/15/01 | |
| Chief Operating Officer | - | 01/17/01 | |
Murali K. P.
BRD | Director/Board Member | - | 01/21/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
K. Paranjothy
CHM | Chairman | 76 | 27/17/27 |
| Director/Board Member | 51 | 11/13/11 | |
| Director/Board Member | 52 | 04/20/04 |
Wintac Limited is an India-based company, which is engaged in the formulations business. The Company is involved in formulation sales, manufacturing charges and formulation development. Its products are classified under categories, including injectable and ophthalmic. Its ophthalmic product range includes Timolol Maleate Eye Drops, Atropine Eye Drops, Fluorometholone Eye Drops, Olopatadine Eye Drops, Chloramphenicol Eye Drops, Diclofenac Eye Drops, Ketorolac Tromethamine Eye Drops and Bromfenac Eye Drops. Its injectable product range includes Diclofenac Injection, Pheniramine Maleate Injection, Iron Sucrose Injection, Pentoxifylline Injection, Atropine Injection, Hyoscine Butyl Bromide Injection, Ondansetron Injection, Metoclopramide Injection, Tramadol Injection, Analgin Injection, Gentamicin Sulphate Injection and Levofloxacin Injection. The Company carries out formulation development activities in the export market, including the United States, Canada, Australia and Europe.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +55.32% | 815B | |
| +44.05% | 641B | |
| -6.75% | 352B | |
| +13.56% | 314B | |
| +10.68% | 303B | |
| +16.57% | 242B | |
| +13.31% | 218B | |
| +8.48% | 168B | |
| -2.81% | 159B |
